JP2009525478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525478A5 JP2009525478A5 JP2008552858A JP2008552858A JP2009525478A5 JP 2009525478 A5 JP2009525478 A5 JP 2009525478A5 JP 2008552858 A JP2008552858 A JP 2008552858A JP 2008552858 A JP2008552858 A JP 2008552858A JP 2009525478 A5 JP2009525478 A5 JP 2009525478A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- prongf
- body fluid
- biological sample
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0600851 | 2006-01-31 | ||
| FR0600851A FR2896881B1 (fr) | 2006-01-31 | 2006-01-31 | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| PCT/FR2007/050708 WO2007088305A1 (fr) | 2006-01-31 | 2007-01-30 | Procede de dosage du prongf pour le diagnostic in vitro du cancer en particulier du cancer du sein, de la thyroide ou du poumon et utilisation du prongf en therapie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012124525A Division JP5792121B2 (ja) | 2006-01-31 | 2012-05-31 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009525478A JP2009525478A (ja) | 2009-07-09 |
| JP2009525478A5 true JP2009525478A5 (https=) | 2010-03-04 |
| JP5091876B2 JP5091876B2 (ja) | 2012-12-05 |
Family
ID=36741378
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552858A Active JP5091876B2 (ja) | 2006-01-31 | 2007-01-30 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
| JP2012124525A Active JP5792121B2 (ja) | 2006-01-31 | 2012-05-31 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012124525A Active JP5792121B2 (ja) | 2006-01-31 | 2012-05-31 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8008009B2 (https=) |
| EP (1) | EP1982192B1 (https=) |
| JP (2) | JP5091876B2 (https=) |
| CN (2) | CN101395478B (https=) |
| ES (1) | ES2471126T3 (https=) |
| FR (1) | FR2896881B1 (https=) |
| WO (1) | WO2007088305A1 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2896881B1 (fr) * | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| AU2009253675A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| FR2944019B1 (fr) * | 2009-04-03 | 2011-04-22 | Biomerieux Sa | Procede de dosage de la prodefensine-a6 pour le diagnostic in vitro du cancer colorectal. |
| EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| CN101782585A (zh) * | 2010-02-10 | 2010-07-21 | 广州医学院 | 肺癌组织蛋白印迹膜片及其制备方法 |
| US20130115222A1 (en) * | 2010-06-15 | 2013-05-09 | Cornell University | Methods of limiting microvascular damage following acute myocardial ischemia |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2737317A2 (en) * | 2011-07-28 | 2014-06-04 | The Trustees Of The University Of Pennsylvania | Methods for diagnosing cancer by characterization of tumor cells associated with pleural or serous fluids |
| US10513737B2 (en) | 2011-12-13 | 2019-12-24 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| EP2885640B1 (en) | 2012-08-16 | 2018-07-18 | Genomedx Biosciences, Inc. | Prostate cancer prognostics using biomarkers |
| CN103122390B (zh) * | 2013-03-07 | 2015-04-08 | 上海市疾病预防控制中心 | Frat1基因作为检测甲状腺癌的血清标志物及其应用 |
| EP2968988A4 (en) | 2013-03-14 | 2016-11-16 | Allegro Diagnostics Corp | METHOD FOR EVALUATING A COPD STATUS |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| CN103866039B (zh) * | 2014-04-04 | 2015-05-27 | 厦门大学 | 人类甲状腺癌组织基因特异位点甲基化水平检测引物及其应用 |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10365272B2 (en) * | 2014-07-25 | 2019-07-30 | Serum Institute Of India Private Limited | Highly sensitive immunoassay for rapid quantification of meningococcal capsular polysaccharide antigens |
| US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| WO2016164608A1 (en) | 2015-04-07 | 2016-10-13 | Alector Llc | Methods of screening for sortilin binding antagonists |
| SI3280441T1 (sl) | 2015-04-07 | 2022-01-31 | Alector Llc | Protitelesa anti-sortilin in metoda njihove uporabe |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| US20200102617A1 (en) * | 2017-01-24 | 2020-04-02 | Genetic Technologies Limited | Improved Methods For Assessing Risk of Developing Breast Cancer |
| CA3055925A1 (en) | 2017-03-09 | 2018-09-13 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| AU2018266733A1 (en) | 2017-05-12 | 2020-01-16 | Veracyte, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
| JP2020523612A (ja) * | 2017-06-08 | 2020-08-06 | カルシディア バイオテクノロジーズＣａｒｃｉｄｉａｇ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ | 癌幹細胞の単離および検出方法 |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| LT3618928T (lt) | 2018-07-13 | 2023-04-11 | Alector Llc | Anti-sortilino antikūnai ir jų panaudojimo būdai |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548062B2 (en) * | 2000-02-29 | 2003-04-15 | Cephalon, Inc. | Method of treating cancer with anti-neurotrophin agents |
| ES2268387T3 (es) | 2002-03-13 | 2007-03-16 | Biomerieux | Procedimiento de deteccion y de cuantificacion de celulas tumorales circulantes, procedentes de canceres solidos. |
| FR2846426B1 (fr) * | 2002-10-28 | 2004-12-10 | Bio Merieux | Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie |
| EP1891966B1 (en) * | 2002-12-20 | 2012-02-15 | H. Lundbeck A/S | Modulation of activity of neurotrophins; screening method |
| WO2005076695A2 (en) * | 2004-02-11 | 2005-08-25 | Painceptor Pharma Corporation | Methods of modulating neurotrophin-mediated activity |
| FR2896881B1 (fr) * | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
-
2006
- 2006-01-31 FR FR0600851A patent/FR2896881B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-30 ES ES07731536.4T patent/ES2471126T3/es active Active
- 2007-01-30 US US12/087,606 patent/US8008009B2/en active Active
- 2007-01-30 JP JP2008552858A patent/JP5091876B2/ja active Active
- 2007-01-30 CN CN2007800040238A patent/CN101395478B/zh not_active Expired - Fee Related
- 2007-01-30 WO PCT/FR2007/050708 patent/WO2007088305A1/fr not_active Ceased
- 2007-01-30 EP EP07731536.4A patent/EP1982192B1/fr active Active
- 2007-01-30 CN CN2013103889291A patent/CN103446585A/zh active Pending
-
2011
- 2011-07-20 US US13/137,101 patent/US20110293636A1/en not_active Abandoned
-
2012
- 2012-05-31 JP JP2012124525A patent/JP5792121B2/ja active Active
- 2012-06-26 US US13/533,908 patent/US9061045B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009525478A5 (https=) | ||
| Wilmott et al. | Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma | |
| Houshmand et al. | Chronic myeloid leukemia stem cells | |
| Liu et al. | Deubiquitinase activity profiling identifies UCHL1 as a candidate oncoprotein that promotes TGFβ-induced breast cancer metastasis | |
| Mercer et al. | Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF | |
| Kelly et al. | The dynamic and transient immune microenvironment in locally advanced esophageal adenocarcinoma post chemoradiation | |
| Syn et al. | NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease | |
| Wu et al. | Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo | |
| US9670550B2 (en) | Method for examination of carcinogenic risk | |
| US12352752B2 (en) | Application of Niemann-Pick C1 protein in diagnosis and treatment of cancer | |
| Chu et al. | Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non–small-cell lung cancer receiving endostatin and paclitaxel–carboplatin chemotherapy? A Retrospective Study | |
| Wang et al. | The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography | |
| Lerévérend et al. | Enhanced expression of galectin‐9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy | |
| Dudek et al. | Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma | |
| Tarhini et al. | Operable melanoma: screening, prognostication, and adjuvant and neoadjuvant therapy | |
| US20090226901A1 (en) | Method of evaluating or selecting agents for preventing or improving pigmented spots | |
| CN112262157A (zh) | 化药抗性癌症的组合治疗 | |
| US20210208161A1 (en) | CCL24 as a Diagnostic and Therapeutic Target for Breast Cancer | |
| Ollila-Raj et al. | Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing | |
| RU2436102C1 (ru) | Способ прогнозирования метастазов рака шейки матки | |
| Robertson | THE PLANTAR MECHANICAL MICROENVIRONMENT PROMOTES PROLIFERATION AND INVASION OF ACRAL MELANOMAS | |
| CN119700754A (zh) | Ido1抑制剂在制备治疗儿童脓毒症相关性胸腺萎缩的药物中的应用 | |
| He et al. | The Expression of PD-L1, CD47, CD4, and CD8 in Breast Cancer before and after Neoadjuvant Chemotherapy and Their Relationship with Clinicopathological Features and Prognosis | |
| Lee et al. | A NON-GENETICALLY ENGINEERED EGFR SPECIFIC ARMED T-CELL THERAPY FOR TREATING EGFR-POSITIVE SOLID TUMORS | |
| Alessandro et al. | 225 ALK. CAR-T cells as a new potential treatment for ALK+ merkel cell carcinoma |